Location: New York, NY
CIK: 0001855655 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $5.341B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | 480,000 | $144M | 2.7% | — | — | COM | 02043Q107 |
| MBX | MBX BIOSCIENCES INC | 2,508,015 | $138M | 2.6% | — | — | COM | 55287L101 |
| JBIO | JADE BIOSCIENCES INC | 2,857,405 | $63.49M | 1.2% | — | — | COM NEW | 008064206 |
| ACHV | ACHIEVE LIFE SCIENCE INC | 4,951,856 | $32.34M | 0.6% | — | — | COM | 004468500 |
| MPLT | MAPLIGHT THERAPEUTICS INC | 685,852 | $24.58M | 0.5% | — | — | COM | 56565P103 |
| KARD | KARDIGAN INC | 900,000 | $21.46M | 0.4% | — | — | COM | 485925101 |
| EDIT | EDITAS MEDICINE INC | 5,586,625 | $18.1M | 0.3% | — | — | COM | 28106W103 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SYRE | SPYRE THERAPEUTICS INC | 3,840,778 (+96.2%) | $341M (+245.4%) | 6.4% | — | — | COM NEW | 00773J202 |
| NUVL | NUVALENT INC | 5,924,433 (+11.3%) | $732M (+34.1%) | 13.7% | — | — | COM | 670703107 |
| EWTX | EDGEWISE THERAPEUTICS INC | 10,215,455 (+38.7%) | $415M (+78.9%) | 7.8% | — | — | COM | 28036F105 |
| GMAB | GENMAB A/S | 13,133,131 (+64.8%) | $361M (+68.8%) | 6.8% | — | — | SPONSORED ADS | 372303206 |
| TNGX | TANGO THERAPEUTICS INC | 6,357,523 (+58.6%) | $199M (+136.9%) | 3.7% | — | — | COM | 87583X109 |
| APGE | APOGEE THERAPEUTICS INC | 1,576,385 (+16.9%) | $209M (+84.4%) | 3.9% | — | — | COM | 03770N101 |
| INSM | INSMED INC | 1,325,977 (+5.7%) | $141M (-31.1%) | 2.6% | — | — | COM PAR $.01 | 457669307 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 6,723,788 (+113.5%) | $124M (+100.5%) | 2.3% | — | — | COM | 92790C104 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 1,553,748 (+133.6%) | $42.7M (+131.3%) | 0.8% | — | — | COM NEW | 045396207 |
| BLTE | BELITE BIO INC | 1,232,877 (+10.6%) | $190M (+6.8%) | 3.6% | — | — | SPONSORED ADS | 07782B104 |
| OLMA | OLEMA PHARMACEUTICALS INC | 8,670,576 (+8.1%) | $108M (-9.3%) | 2.0% | — | — | COM | 68062P106 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,775,649 (+8.3%) | $175M (-2.8%) | 3.3% | — | — | COM | 87650L103 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 5,774,016 | $663M | 12.4% | — | — | — | 03940C100 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 3,574,048 | $142M | 2.7% | — | — | — | 152309100 |
| TERN | TERNS PHARMACEUTICALS INC | 2,216,499 | $117M | 2.2% | — | — | — | 880881107 |
| CYTK | CYTOKINETICS INC | 1,480,857 | $97.6M | 1.8% | — | — | — | 23282W605 |
| ABVX | ABIVAX SA | 772,473 | $86.01M | 1.6% | — | — | — | 00370M103 |
| MAZE | MAZE THERAPEUTICS INC | 2,744,399 | $81.92M | 1.5% | — | — | — | 578784100 |
| SRRK | SCHOLAR ROCK HLDG CORP | 1,226,080 | $60.27M | 1.1% | — | — | — | 80706P103 |
| MIRM | MIRUM PHARMACEUTICALS INC | 625,000 | $57.74M | 1.1% | — | — | — | 604749101 |
| MANE | VERADERMICS INC | 525,000 | $33.15M | 0.6% | — | — | — | 922967104 |
| URGN | UROGEN PHARMA LTD | 1,703,949 | $30.64M | 0.6% | — | — | — | M96088105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 545,287 | $26.28M | 0.5% | — | — | — | 86366E106 |
| ORIC | ORIC PHARMACEUTICALS INC | 1,701,217 | $21.55M | 0.4% | — | — | — | 68622P109 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 868,213 | $7.771M | 0.1% | — | — | — | 107924102 |
| KLRS | KALARIS THERAPEUTICS INC | 700,000 | $4.039M | 0.1% | — | — | — | 482929106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 6,361,323 (-4.4%) | $1.191B (+84.1%) | 22.3% | — | — | COM | 76155X100 |
| PCVX | VAXCYTE INC | 2,127,852 (-55.6%) | $124M (-55.6%) | 2.3% | — | — | COM | 92243G108 |
| ORKA | ORUKA THERAPEUTICS INC | 2,144,526 (-7.6%) | $204M (+79.3%) | 3.8% | — | — | COM | 687604108 |
| TYRA | TYRA BIOSCIENCES INC | 1,828,607 (-11.0%) | $58.41M (-25.8%) | 1.1% | — | — | COM | 90240B106 |
| LXEO | LEXEO THERAPEUTICS INC | 4,175,382 (-32.5%) | $19.44M (-45.2%) | 0.4% | — | — | COM | 52886X107 |
| ERAS | ERASCA INC | 9,550,000 (-8.1%) | $175M (+4.0%) | 3.3% | — | — | COM | 29479A108 |
| EYPT | EYEPOINT INC | 2,890,397 (-8.0%) | $41.33M (+2.0%) | 0.8% | — | — | COM NEW | 30233G209 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IVA | INVENTIVA SA | 4,000,000 | $15.12M | 0.3% | — | — | ADS | 46124U107 |
| VOR | VOR BIOPHARMA INC | 1,750,000 | $32.22M | 0.6% | — | — | COM NEW | 929033207 |